Patents by Inventor Intrexon Corporation

Intrexon Corporation has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Engineered Dendritic Cells and Uses for the Treatment of Cancer
    Publication number: 20130149290
    Abstract: This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL-12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human.
    Type: Application
    Filed: January 9, 2013
    Publication date: June 13, 2013
    Applicants: University Of Pittsburgh-Of The Commonwealth System Of Higher Education, Intrexon Corporation
    Inventors: Intrexon Corporation, University Of Pittsburgh-Of The Commonwealth System Of Higher Education